title: Despite extensive efforts, the validation of prognostic tissue markers in prostate cancer has not yet resulted in the widespread implementation of novel diagnostic tests.
authors.affiliation: Department of Pathology, Erasmus Medical Centre, Rotterdam, The Netherlands. g.vanleenders@erasmusmc.nl
authors.forename: Geert
authors.initials: G
authors.lastname: van Leenders
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis* / Q000235:genetics; D014408:Biomarkers, Tumor / Q000235:genetics*; D015342:DNA Probes; D018628:Gene Dosage; D016259:Genes, myc / Q000235:genetics*; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D008297:Male; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000235:genetics
chemical_list: D014408:Biomarkers, Tumor; D015342:DNA Probes